LTIM.NS stock INR 4559.00 pre-market 26 Feb 2026: $100.00m medtech AI deal hints upside
The LTIM.NS stock opened pre-market at INR 4559.00 on 26 Feb 2026 after Reuters reported a $100.00m contract win with a European medtech firm. Investors are parsing the deal for AI-led revenue upside even as the Nifty IT sector trades under pressure. LTIMindtree Limited (LTIM.NS) shows a one-day gain of 1.29% and trading volume near 370,208 shares. We outline fundamentals, technicals, Meyka AI grade, and a price forecast that frames short and medium term market moves.
Pre-market snapshot: LTIM.NS stock and trade context
LTIM.NS stock is quoted on the NSE in India at INR 4559.00 pre-market on 26 Feb 2026. The share recorded a previous close of INR 4501.00, an open of INR 4524.00, day low INR 4515.50, and day high INR 4661.50. Volume early is 370,208 versus an average volume of 317,911, giving a relative volume of 1.16.
Sector pressure is evident. The Nifty IT index has weakened amid AI adoption concerns and a valuation reset. Market participants are weighing LTIMindtree’s deal flow against slower sector sentiment source.
Earnings and fundamentals: LTIM.NS stock financial snapshot
LTIMindtree Limited (LTIM.NS) posts EPS 160.41 and a trailing PE of 28.42. Market cap stands at approximately INR 1,351,290,276,133.00 with 296,400,587.00 shares outstanding. Key ratios show price to sales 3.31, price to book 5.70, and dividend per share 67.00.
Operating metrics remain healthy. Return on equity is 20.57%, debt to equity 0.18, and current ratio 3.19. Free cash flow yield is 3.02%, supporting dividends but leaving valuation stretched versus some peers.
AI strategy and deal flow: why the $100.00m medtech contract matters
LTIMindtree’s anonymous $100.00m contract with a European medtech client highlights AI and platform work that can lift higher-margin digital revenue. The deal signals execution in healthcare tech where LTIMindtree competes on cloud and AI platforms. Reuters covered the contract on 23 Feb 2026 source.
For investors tracking AI stocks, contract size matters. A multi-year implementation can add predictable revenue and improve blended margins if services shift to platform and IP-led models.
Valuation and technicals: LTIM.NS stock trading view
Technically LTIM.NS shows oversold momentum. RSI stands at 19.93, MACD histogram is negative, and ADX is 37.89, indicating a strong trend. Bollinger lower band sits near INR 4419.38 while the 50-day average is INR 5878.82.
Valuation presents a trade-off. The PE of 28.42 sits near the tech sector average of ~41.22 but above several Indian IT peers. Price to book 5.70 flags premium valuation, while strong cash conversion and low net debt support balance-sheet resilience.
Meyka Grade and forecast: LTIM.NS stock score and outlook
Meyka AI rates LTIM.NS with a score out of 100: 79.87 (B+) — BUY. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. The grade balances strong ROE and cash metrics against stretched valuation and sector headwinds.
Meyka AI’s forecast model projects a 1-year target of INR 6404.66. Versus the current price INR 4559.00, that implies a modeled upside of 40.49%. Forecasts are model-based projections and not guarantees. For more details visit Meyka AI stock page for LTIM.NS (internal analysis).
Trading plan and risks for AI stock investors
Short-term traders can watch INR 4419.38 as immediate support and INR 4661.50 as the day high resistance. A conservative price target for a 3-6 month hold is INR 5000.00, while the Meyka 12-month model target is INR 6404.66.
Key risks include a broader IT valuation reset, slower discretionary IT spend, and margin pressure in low-margin legacy services. Positive catalysts are additional AI deal announcements, higher-margin platform wins, and better-than-expected earnings guidance.
Final Thoughts
LTIM.NS stock trades at INR 4559.00 pre-market on 26 Feb 2026 after a reported $100.00m medtech contract. Fundamentals show solid profitability with EPS 160.41 and ROE 20.57%, but valuation metrics such as PE 28.42 and PB 5.70 ask for growth delivery. Meyka AI rates LTIM.NS B+ (79.87) — BUY, reflecting strong operational metrics versus sector weakness. Meyka AI’s forecast model projects INR 6404.66 in 12 months, implying 40.49% upside from current levels. Traders should balance the model outlook with technical oversold signals and sector headwinds. Use layered entries and set stop-losses near INR 4419.38 if broader IT sentiment deteriorates. Forecasts are model-based projections and not guarantees.
FAQs
What is the current price and pre-market status of LTIM.NS stock?
LTIM.NS stock is at INR 4559.00 pre-market on 26 Feb 2026. Volume early is 370,208 versus average 317,911. Day range so far is INR 4515.50–INR 4661.50.
How does Meyka AI rate LTIM.NS stock and why?
Meyka AI rates LTIM.NS 79.87 (B+) — BUY. The score reflects strong ROE, cash flow, and forecast upside, offset by premium valuation and sector headwinds.
What price target and upside does Meyka AI forecast for LTIM.NS stock?
Meyka AI’s forecast model projects INR 6404.66 in 12 months. Versus the current INR 4559.00, that implies an upside of 40.49%. Models are projections, not guarantees.
What risks should investors watch for LTIM.NS stock?
Key risks include a broader IT valuation reset, slower enterprise IT spend, and margin pressure in legacy services. Watch sector news and quarterly guidance for early signs of deterioration.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.